Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results)
The article presents the results of screening data from a simultaneous study of 443 outpatient cards of patients with schizophrenic spectrum disorders who were under dynamic outpatient monitoring in two areas of the psycho-neurological dispensary No. 2 in Moscow in order to assess the incidence of t...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849245136285859840 |
|---|---|
| author | L. N. Gorobets M. A. Tsarenko A. V. Litvinov L. M. Vasilenko |
| author_facet | L. N. Gorobets M. A. Tsarenko A. V. Litvinov L. M. Vasilenko |
| author_sort | L. N. Gorobets |
| collection | DOAJ |
| description | The article presents the results of screening data from a simultaneous study of 443 outpatient cards of patients with schizophrenic spectrum disorders who were under dynamic outpatient monitoring in two areas of the psycho-neurological dispensary No. 2 in Moscow in order to assess the incidence of type 2 diabetes mellitus (T2DM), and also metabolic disorders (MD) in patients with prolonged anti-relapse antipsychotic therapy. The incidence of these disorders as a whole was 24.6%. Differences in the prevalence of diabetes mellitus 2 and MN were considered depending on the gender of the patient and the antipsychotic used. The obtained data on the high frequency of occurrence of the above metabolic disorders indicate the need to develop standards for antipsychotic therapy of patients with schizophrenic spectrum disorders when combined with T2DM and MD. |
| format | Article |
| id | doaj-art-55fd27abc03b4cbea2c70fdfaf776fbb |
| institution | Kabale University |
| issn | 2313-7053 2713-055X |
| language | Russian |
| publishDate | 2019-07-01 |
| publisher | Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation |
| record_format | Article |
| series | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| spelling | doaj-art-55fd27abc03b4cbea2c70fdfaf776fbb2025-08-20T03:58:55ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2019-07-0102374510.31363/2313-7053-2019-2-37-45243Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results)L. N. Gorobets0M. A. Tsarenko1A. V. Litvinov2L. M. Vasilenko3Moscow Research Institute of Psychiatry, Branch of National Medical Research Center of Psychiatry and Narcology of Health Ministry of RussiaMoscow City Psycho-Endocrinological CenterMoscow Research Institute of Psychiatry, Branch of National Medical Research Center of Psychiatry and Narcology of Health Ministry of RussiaMoscow Research Institute of Psychiatry, Branch of National Medical Research Center of Psychiatry and Narcology of Health Ministry of RussiaThe article presents the results of screening data from a simultaneous study of 443 outpatient cards of patients with schizophrenic spectrum disorders who were under dynamic outpatient monitoring in two areas of the psycho-neurological dispensary No. 2 in Moscow in order to assess the incidence of type 2 diabetes mellitus (T2DM), and also metabolic disorders (MD) in patients with prolonged anti-relapse antipsychotic therapy. The incidence of these disorders as a whole was 24.6%. Differences in the prevalence of diabetes mellitus 2 and MN were considered depending on the gender of the patient and the antipsychotic used. The obtained data on the high frequency of occurrence of the above metabolic disorders indicate the need to develop standards for antipsychotic therapy of patients with schizophrenic spectrum disorders when combined with T2DM and MD.https://www.bekhterevreview.com/jour/article/view/246antipsychoticsschizophrenia spectrum disorderstype ii diabetesmetabolic instability. |
| spellingShingle | L. N. Gorobets M. A. Tsarenko A. V. Litvinov L. M. Vasilenko Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева antipsychotics schizophrenia spectrum disorders type ii diabetes metabolic instability. |
| title | Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) |
| title_full | Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) |
| title_fullStr | Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) |
| title_full_unstemmed | Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) |
| title_short | Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results) |
| title_sort | frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti relapse antipsychotic therapy based on screening results |
| topic | antipsychotics schizophrenia spectrum disorders type ii diabetes metabolic instability. |
| url | https://www.bekhterevreview.com/jour/article/view/246 |
| work_keys_str_mv | AT lngorobets frequencyofoccurrenceoftype2diabetesandmetabolicdisturbancesinpatientswithschizophrenicrangedisorderswithprolongedantirelapseantipsychotictherapybasedonscreeningresults AT matsarenko frequencyofoccurrenceoftype2diabetesandmetabolicdisturbancesinpatientswithschizophrenicrangedisorderswithprolongedantirelapseantipsychotictherapybasedonscreeningresults AT avlitvinov frequencyofoccurrenceoftype2diabetesandmetabolicdisturbancesinpatientswithschizophrenicrangedisorderswithprolongedantirelapseantipsychotictherapybasedonscreeningresults AT lmvasilenko frequencyofoccurrenceoftype2diabetesandmetabolicdisturbancesinpatientswithschizophrenicrangedisorderswithprolongedantirelapseantipsychotictherapybasedonscreeningresults |